CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Multi-Center, Parallel-Group, Safety and Efficacy Study of Lotemax® Gel 0.5% and Restasis 0.05% for 12 Weeks in Subjects With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease; DED)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01817582
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:35.959150+00:00
Published At: 2019-08-30T00:00:00+00:00
Record Updated At: 2019-08-30
Results Posted At: 2019-08-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Keratoconjunctivitis Sicca"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-08-30"
protocolSection.identificationModule.nctId: "NCT01817582"
protocolSection.identificationModule.officialTitle: "A Randomized, Multi-Center, Parallel-Group, Safety and Efficacy Study of Lotemax\u00ae Gel 0.5% and Restasis 0.05% for 12 Weeks in Subjects With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease; DED)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2019-08-30"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.